title: [Management of hypothyroidism secondary to tyrosine kinase inhibitors: description of treatment in three distinct clinical settings].
authors.forename: Gilberto
authors.initials: G
authors.lastname: Pérez López
authors.forename: Marta
authors.initials: M
authors.lastname: Carrasco De La Fuente
authors.forename: Miriam
authors.initials: M
authors.lastname: Menacho Román
authors.forename: Olga
authors.initials: O
authors.lastname: González Albarrán
authors.forename: Marta
authors.initials: M
authors.lastname: Cano Megías
mesh_terms: D000328:Adult; D001549:Benzamides; D001557:Benzenesulfonates / Q000009:adverse effects / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000188:drug therapy; D002828:Choristoma / Q000188:drug therapy; D005260:Female; D046152:Gastrointestinal Stromal Tumors / Q000556:secondary; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced* / Q000188:drug therapy; D000068877:Imatinib Mesylate; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy; D008875:Middle Aged; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use; D010995:Pleural Diseases / Q000188:drug therapy; D047428:Protein Kinase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use; D011758:Pyrroles / Q000009:adverse effects / Q000627:therapeutic use; D000077157:Sorafenib; D000077210:Sunitinib; D013950:Thymus Gland; D013974:Thyroxine / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D001549:Benzamides; D001557:Benzenesulfonates; D007211:Indoles; D010671:Phenylurea Compounds; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011725:Pyridines; D011743:Pyrimidines; D011758:Pyrroles; D009536:Niacinamide; D000068877:Imatinib Mesylate; D000077157:Sorafenib; D011505:Protein-Tyrosine Kinases; D013974:Thyroxine; D000077210:Sunitinib